PLOS ONE: A First-Time-In-Human Phase I Clinical Trial of Bispecific Antibody-Targeted, Paclitaxel-Packaged Bacterial Minicells
Nab-paclitaxel versus solvent-based paclitaxel in patients with previously treated advanced gastric cancer (ABSOLUTE): an open-label, randomised, non-inferiority, phase 3 trial - The Lancet Gastroenterology & Hepatology
Pembrolizumab versus paclitaxel for previously treated, advanced gastric or gastro-oesophageal junction cancer (KEYNOTE-061): a randomised, open-label, controlled, phase 3 trial - The Lancet
Frontiers | Targeting Strategies for Enhancing Paclitaxel Specificity in Chemotherapy | Cell and Developmental Biology
Comparison of Pivotal Clinical Trials of Paclitaxel Coated Balloons | CFR Journal
HER2 and Response to Paclitaxel in Node-Positive Breast Cancer | NEJM
Paclitaxel nanoformulations that are approved or in clinical trials for... | Download Scientific Diagram
Paclitaxel Poliglumex - an overview | ScienceDirect Topics
Paclitaxel nanoformulations that are approved or in clinical trials for... | Download Scientific Diagram
Open-label randomized clinical trial of standard neoadjuvant chemotherapy with paclitaxel followed by FEC versus the combination of paclitaxel and everolimus followed by FEC in women with triple receptor-negative breast cancer† - Annals
Diagram of the study; clinical trial flow chart. A total of 100... | Download Scientific Diagram
Paclitaxel and Carboplatin for Carcinoma Clinical Trial | Power
A randomized phase III trial in patients with recurrent platinum sensitive ovarian cancer comparing efficacy and safety of paclitaxel micellar and Cremophor EL-paclitaxel - Gynecologic Oncology
Immunotherapy as a treatment strategy in advanced stage and recurrent endometrial cancer: review of current phase III immunotherapy clinical trials - Ramez N. Eskander, Matthew A. Powell, 2021
CIRSE 2019: Hear the latest from clinical trials comparing paclitaxel technologies head-to-head - Vascular News
Randomised, double-blind trial of carboplatin and paclitaxel with daily oral cediranib or placebo in patients with advanced non-small cell lung cancer: NCIC Clinical Trials Group study BR29 - European Journal of Cancer
Caveolin-1 expression predicts efficacy of weekly nab-paclitaxel plus gemcitabine for metastatic breast cancer in the phase II clinical trial | BMC Cancer | Full Text
Nanoparticle Albumin-bound Paclitaxel Plus Carboplatin Induction Followed by Nanoparticle Albumin-bound Paclitaxel Maintenance in Squamous Non–Small-cell Lung Cancer (ABOUND.sqm): A Phase III Randomized Clinical Trial - Clinical Lung Cancer
Clinical Trials Included in the Meta-Analysis | Download Table
Efficacy and safety findings from DREAM: a phase III study of DHP107 (oral paclitaxel) versus i.v. paclitaxel in patients with advanced gastric cancer after failure of first-line chemotherapy - Annals of Oncology
FDA: Paclitaxel device clinical trials “may continue”
Flow chart of study population of the PICCOLETO trial. PCB,... | Download Scientific Diagram
Paclitaxel (Taxol) in breast cancer adjuvant therapy: chronology of... | Download Scientific Diagram
![CLINICAL TRIALS [GANNET53]](http://gannet53.eu/_media/concept_of_eudario.png "CLINICAL TRIALS [GANNET53]")
CLINICAL TRIALS [GANNET53]
nab-Paclitaxel as a potential partner with checkpoint inhibitors in so | OTT
Efficacy and safety of first-line veliparib and carboplatin–paclitaxel in patients with HER2− advanced germline BRCA+ breast cancer: Subgroup analysis of a randomised clinical trial - European Journal of Cancer
.jpg "HaiHe Biopharma's Oral Paclitaxel RMX3001 Granted Clinical Trial Approval by CNDA")
HaiHe Biopharma's Oral Paclitaxel RMX3001 Granted Clinical Trial Approval by CNDA
